Cargando…
Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
Prostate cancer (PCa) is the most common cancer in men, and more than 10% of men will be diagnosed with PCa during their lifetime. Patients that are not cured with surgery or radiation are largely treated with endocrine therapies that target androgens or the androgen receptor (AR), a major driver of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600138/ https://www.ncbi.nlm.nih.gov/pubmed/31142021 http://dx.doi.org/10.3390/ijms20112626 |